Announcement

Collapse
No announcement yet.

Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine

Collapse
X
Collapse
  •  

  • Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine

    COPENHAGEN, Denmark, August 9, 2021 – Bavarian Nordic A/S (OMX: BAVA) today reported initial results from the first-in-human trial of ABNCoV2, led by the PREVENT-nCoV consortium.


    More...
      Posting comments is disabled.

    Categories

    Collapse

    Article Tags

    Collapse

    There are no tags yet.

    Latest Articles

    Collapse

    Working...
    X